Emalex Receives U.S. Patent for Orally Disintegrating Ecopipam Formulation

Emalex Biosciences today announced that the U.S. Patent and Trademark Office issued a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 receptor ...
Medindia

Easy-to-Swallow Lasmiditan Tablets for Migraine Pain

World’s first dispersible tablets of Lasmiditan, designed to deliver rapid migraine relief by selectively targeting a ...

Capecitabine Market Outlook 2026-2030 Shows 9% CAGR as Innovations in Therapies and Homecare Treatment Adoption Accelerate Industry Growth

The report details market characteristics, size, growth, segmentation, and geographic breakdowns. Additionally, the report ...
Fabbaloo

Dose by Design: Pharmaceutical 3D Printing and the Future of Pediatric Compounding

Charles R. Goulding and Andressa Bonafe highlight the shift from clinical pilot programs to everyday pharmacy practice, where ...
Pharmabiz

Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care

Akums Drugs & Pharmaceuticals Ltd. has announced the launch of the world’s first Lasmiditan dispersible tablets, marking an important step forward in the treatment of acute migraine. The DCGI-approved ...
IEEE

Co-processed excipients-A step towards better drug product performance

Abstract: Aim: The aim of the study is to focus on the significance of co-processed excipients in drug delivery and product performance. Methodology: In current study comparative evaluation of drug ...
The Mirror

‘I have 16 tablets left’ pharmacies run out of aspirin as government slaps UK export ban

The government placed aspirin on its export ban list to safeguard UK supplies and chemists across the nation are running dry. The National Pharmacy Association chair Olivier Picard featured on BBC ...
Morningstar

Precipitated Silica Market to Reach USD 7.0 Billion by 2036 Driven by Tire Performance, Oral Care Demand, and Specialty Formulations

NEWARK, DELAWARE / ACCESS Newswire / February 12, 2026 / The global Precipitated Silica Market is valued at USD 4.3 billion in 2026 and is projected to reach USD 7.0 billion by 2036, expanding at a ...
Morningstar

Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that Health Canada has authorized the tablet formulation of LIVMARLI® (maralixibat) for the treatment of ...
ascopubs.org

Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms

In the article that accompanies this editorial, Driever et al 6 present results that led to the US Food and Drug Administration approval of selumetinib for children age 1 year or older with ...
Wall Street Journal

Pill Version of Wegovy Is Approved for Use in the U.S.

U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B0.51%increase; green up pointing triangle Ozempic and Wegovy—ushering in a new era of the obesity ...
SciELO

Formulation and in vitro evaluation of taste-masked oro-dispersible dosage form of diltiazem hydrochloride

Diltiazem hydrochloride is a calcium channel blocker generally indicated for the treatment of angina and hypertension, and it is extensively metabolized due to the hepatic metabolism. Formulation of ...